Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

AbbVie

These two growth stocks should take very different trajectories as they expand.

Which Stock Is More Likely to 5X First: AbbVie or Tilray Brands?

Aurora Cannabis

Canopy Growth

Even if federal legalization happens, would that really make marijuana stocks good investments?

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Bounced Today

AMC Entertainment

Annaly Capital

While investors are hoping for a quick end to the current bear market, recent data signals it's not likely to be over soon. The September core consumer price index, which excludes food and energy prices, hit a 40-year high.

3 Stocks You'll Be Glad You Don't Own in This Bear Market

Bitfarms Ltd

Borr Drilling Ltd

Economic uncertainty is reflected in the markets, with volatility remaining high. The bear-bull spread indicator clearly reflects the nervousness in the markets.

3 Penny Stocks to Buy if You Are Feeling Greedy

AdvisorShares Pure US Cannabis ETF

If you can tolerate the risk, buying pot stocks at a discount today could make for a tidy profit in the future.

Why Pot Stocks Could Be Your Best Bear Market Buy

Year-Round Brews Bolster WEST COAST IPA® Lineup Year-Round Brews Bolster WEST COAST IPA® Lineup

Green Flash Launches New Beers Across the U.S. and Unveils Refreshed Branding

Which marijuana stock is more likely to succeed in the long term? Cannabis stocks have been on fire of late as hopes surrounding marijuana reform in the U.S. have put them back into the spotlight. Today I'll look at two of the most popular cannabis stocks on the Nasdaq: Tilray Brands (TLRY 6.21%) and SNDL (SNDL 7.03%).

Better Growth Stock: SNDL vs. Tilray

Canadian weed companies have great staying power, a government data set reveals.

Why Canopy Growth and Tilray Blasted Higher Today

This beaten-down pot stock has a real shot at delivering 2,000% plus returns by the end of the decade.

Tilray Brands Stock Could Grow by 20 Times by 2030

Innovative Industrial Properties

Trulieve Cannabis Corp.

President Joe Biden's recent pronouncements shook the cannabis industry out of its slumber.

Is This the Best Chance Marijuana Stocks Have for Legalization?

Some companies would be much better positioned than others to take advantage if federal marijuana reform happens.

Which Cannabis Stocks Would Benefit Most From U.S. Federal Legalization?

Cronos Group

Analysts at Stifel said in a note to clients Monday that the underperformance of the cannabis sector was well-founded with the category's risks on full display in 2022. In its latest monthly review of the sector, the broker pointed out that in the year to date the average cannabis stock is down 62%, adding this reflected oversupply, limited differentiation, uneven enforcement against the illicit market, regulatory risk, and outsized exposure to lower-income consumers.

Stifel analysts argue underperformance of the cannabis sector in 2022 is well founded

Top Marijuana Stocks To Watch The Rest Of The Month The post 2 Canadian Marijuana Stocks To Watch The Rest Of The Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks To Watch The Rest Of The Week

80% technical sell signal. Down 1.71% in the last month.

Tilray Brands: Pot Pops Then Drops

Tilray Inc. reported a wider first-quarter loss in the face of revenue headwinds and the impact of unfavorable currency conversions to U.S. dollars, but CEO Irwin Simon said the cannabis company retained its leading market positions in Germany and Canada and that it still holds about $500 million in cash.

Tilray revenue impacted by currency, Canadian headwinds

Tilray Brands, Inc. (NASDAQ:TLRY ) Q1 2023 Results Conference Call October 7, 2022 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - Chairman and CEO Denise Faltischek - Chief Strategy Officer and Head, International Blair MacNeil - President, Canada Carl Merton - CFO Conference Call Participants Vivien Azer - Cowen and Company Andrew Carter - Stifel Andrew Bond - Jefferies Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets Pablo Zuanic - Cantor Fitzgerald Michael Lavery - Piper Sandler Shaan Mir - Canaccord Genuity Glenn Matson - Ladenburg Thalmann Frederico Gomes - ATB Capital Markets John Zamparo - CIBC World Markets Operator Good morning, everyone. Thank you for joining us to discuss Tilray Brands, Inc. Financial Results for the Fiscal Year 2023 First Quarter ended August 31, 2022.

Tilray Brands, Inc. (TLRY) Q1 2023 Earnings Call Transcript

Lucid Group

Pinterest

It's been a bad year for growth stocks. The S&P 500 Pure Growth Index has corrected by 27.5% for year-to-date 2022.

This Is the Best Time to Buy These 3 Long-Term Growth Stocks

President Biden might have just initiated a change in federal marijuana policy that could finally allow Canadian growers to enter the U.S. market.

Why Tilray, Canopy Growth, and Aurora All Crashed Friday

Amplify Alternative Harvest ETF

AdvisorShares Pure Cannabis ETF 

Shares of Florida-based Trulieve Cannabis were trading as much as 47% higher at one point early Friday morning.

Marijuana stocks surge after Biden pardons weed offenders

Tilray Brands, Inc. (TLRY) delivered earnings and revenue surprises of -33.33% and 1.59%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?

Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates

GrowGeneration Corp

SNDL Inc.

Traders got high on cannabis stocks after President Joe Biden announced a pardon for federal marijuana offenders and moved to re-classify it. Tilray Brands (NASDAQ: TLRY ), SNDL (NASDAQ: SNDL ), Canopy Growth (NYSE: CGC ), and GrowGeneration (NASDAQ: GRWG ) all rose at least 20%.

Why Are Cannabis Stocks TLRY, SNDL, CRON, CGC, GRWG Up Today?

Tilray Brands Inc. TLRY, +30.87% said Friday its first-quarter loss narrowed to $65.8 million, or 13 cents a share, from a loss of $34.6 million, or 9 cents a share, in the year-ago quarter. Revenue at the cannabis company fell 9% to $153.2 million.

Tilray narrows net loss but misses analyst estimates

Reported Net Revenue at $153.2 Million; On a Constant Currency Basis, Net Revenue Remained Strong at $166.5 Million

Tilray Brands' First Quarter Fiscal Year 2023 Performance Affirms Global Cannabis Leadership

Which penny stocks are on your watchlist right now? The post Are Penny Stocks Worth Buying Today?

Are Penny Stocks Worth Buying Today? 3 to Watch Right Now

Tilray stock surged almost 40% after following the announcement that the Biden administration took a major step towards the legalization of marijuana. On October 6th, Biden announced that he will pardon all federal marijuana possession convictions, as well as all respective convictions in Washington D.C.

News for Tilray Brands Stock (TLRY)